 |
 |
Jobs - Posted 2 September 2010 Director of the Division of Neuroscience, National Institute on Aging: Department of Health and Human Services, National Institutes of Health, Bethesda, Maryland.
Comments - Posted 1 September 2010 Read remarks by Terrence Town about Boyd TD et al. PAPER: GM-CSF Upregulated in Rheumatoid Arthritis Reverses Cognitive Impairment and Amyloidosis in Alzheimer Mice.
Comments - Posted 1 September 2010 Read remarks by Niklas Mattsson about Siderowf A et al. PAPER: CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.
Comments - Posted 1 September 2010 Read remarks by Elliott Mufson NEWS: Anti-Aβ Oligomer Headed for Phase 3 Clinical Trial
Comments - Posted 1 September 2010 Read remarks by Torleif Härd about Zhuang W et al. PAPER: Discriminating early stage A{beta}42 monomer structures using chirality-induced 2DIR spectroscopy in a simulation study.
Comments - Posted 1 September 2010 Read remarks by Giampaolo Merlini, Laura Obici about Bugiani O et al. PAPER: Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP.
Comments - Posted 1 September 2010 Read remarks by Hugo Geerts NEWS: Lilly Halts IDENTITY Trials as Patients Worsen on Secretase Inhibitor
Comments - Posted 1 September 2010 Read remarks by Jochen Herms NEWS: Lilly Halts IDENTITY Trials as Patients Worsen on Secretase Inhibitor
Research Models: TDP-43 - Posted 1 September 2010 We've added the Tardbp+/- mouse model to our TDP-43 Research Models page.
Comments - Posted 31 August 2010 Read remarks by Thomas Bayer, Vivek Venkataramani about Paris D et al. PAPER: Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease.
In Search of Research Participants - Posted 31 August 2010 California Clinical Trials is conducting a short inpatient medical research study.
Jobs - Posted 31 August 2010 Assistant Professor or Associate Professor: West Virginia University Department of Psychology, Morgantown, West Virginia.
Comments - Posted 31 August 2010 Read remarks by David Teplow about Sandberg A et al. PAPER: Stabilization of neurotoxic Alzheimer amyloid-{beta} oligomers by protein engineering.
Comments - Posted 27 August 2010 Read remarks by Cathy Roe about Paris D et al. PAPER: Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease.
Comments - Posted 27 August 2010 Read remarks by William Klunk about Kadir A et al. PAPER: Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.
Jobs - Posted 26 August 2010 Senior Research Associate-Neuroscience: Genentech, South San Francisco, California.
Jobs - Posted 26 August 2010 Research Associate-Neuroscience: Genentech, South San Francisco, California.
Jobs - Posted 26 August 2010 Scientist-Neuroscience: Genentech, South San Francisco, California.
Conferences - Posted 26 August 2010 Immunological Mechanisms of Vaccination: 27 October 2010 - 1 November 2010, Sheraton Seattle Hotel, Seattle, WA, U.S.A.
Jobs - Posted 26 August 2010 Scientist/Senior Scientist, Neurology Pharmacodynamic Biomarkers: Genentech, South San Francisco, California.
AD Experiences - Posted 26 August 2010 The latest issue (Vol. 15, No. 3) of Perspectives, a quarterly newsletter written for people with dementia, is available on our AD Experiences page.
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Should the FDA be allowed to use data from overseas clinical trials? |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Absolutely, we are running out of viable subjects in the U.S. |
 |
 |
 |
 |
 |
 |
9 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Yes, so long as the data is reliable |
 |
 |
 |
 |
 |
 |
31 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the trials are not as rigorous |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the data should be repeated in the U.S. |
 |
 |
 |
 |
 |
 |
5 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the drug sponsors are just trying to cut corners |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Responses: 51 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Archived Polls |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |